Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.56ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.56ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.56EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.56EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.4.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.4.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.4.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.198EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.198EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.198ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.198ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.198EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.198EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.198ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.198ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.366EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.366EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.366ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.366ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.366EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.366EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.366ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.366ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.441EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.441EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.441ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.441ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.441EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.441EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.441ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.441ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.416EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.416ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.416ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.416EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.416EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.416ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.416ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.63EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.63ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.63ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used